To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Clinical trial NCT06647550 · RECRUITING
Trial details
- NCT number
- NCT06647550
- Sponsor
- Hyundai Pharm
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2025-03-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.